LFVN(LFVN)
LFVN
Signal
Leaning Bullish1↑
PRICE
Prev Close
5.12
Open
5.13
Day Range5.02 – 5.29
5.02
5.29
52W Range3.90 – 15.00
3.90
15.00
11% of range
VOLUME & SIZE
Avg Volume
166.1K
FUNDAMENTALS
P/E Ratio
11.5x
Value territory
EPS (TTM)
—
Div Yield
0.02%
Beta
0.62
Low vol
Performance
1D
+0.98%5D
+1.97%1M↑
+18.85%3M
+2.78%6M
-21.90%YTD
-16.07%1Y↓
-59.00%Best: 1M (+18.85%)Worst: 1Y (-59.00%)
Quick Read
Trend—Insufficient MA data
Momentum
NEUTRAL
rev -12% · 78% gross marginValuation
CHEAP
P/E 11x vs ~20x sectorHealth
STRONG
CR 2.0 · FCF $0.30/shBullish
Key MetricsTTM
Market Cap$65.22M
Revenue TTM$195.32M
Net Income TTM$5.75M
Free Cash Flow$3.77M
Gross Margin78.1%
Net Margin2.9%
Operating Margin3.4%
Return on Equity17.8%
Return on Assets9.3%
Debt / Equity0.31
Current Ratio1.96
EPS TTM$0.46
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
3 strong2 watch1 concern
58/100Liquidity
1.96Watch
Leverage
0.31Strong
Coverage
0.0xConcern
ROE
17.8%Strong
ROIC
12.7%Watch
Cash
$20MStrong
ANALYST COVERAGE2 analysts
BUY
▼ -3.3%downside to target
Stock Health
Composite Score
4 of 5 signals bullish
8/10
Technicals
●
✓RSI RangeRSI 54 — Bullish momentum
Volume
●
✓Volume FlowAccumulation — institutional buying
Fundamentals
●
✗Last EarningsMissed estimates
●
✓Analyst ConsensusBuy
●
✓LiquidityCurrent Ratio 1.96 — healthy liquidity
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 31, 2026
In 107 days
FinancialsFull statements →
Technicals
Technical SetupBULLISH
Technicals →Trend
▲ RallyDeath Cross · 50D trails 200D by 34.8%
+7.5% vs SMA 50 · -29.9% vs SMA 200
Momentum
RSI53.8Neutral territory
MACD+0.13Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$15.00+190.1%
EMA 200
$7.58+46.5%
Current
$5.17
EMA 50
$5.03-2.7%
52W Low
$3.90-24.6%
52-Week RangeNear 52-week low
$3.9011th %ile$15.00
Squeeze SetupVolume-based
Moderate Squeeze SetupAccumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
20-Day Money Flow
Acc days:8
Dist days:6
Edge:+2 acc
Volume Context
Avg Vol (50D)170K
Recent Vol (5D)
138K-19%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 2 analysts
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2024 | $202.2M $198.6M–$204.6M | — | $0.65 | — | ±9% | Low1 |
FY2025 | $230.3M $226.2M–$233.0M | ▲ +13.9% | $0.81 | ▲ +24.6% | ±2% | Low1 |
FY2026(current) | $184.2M $180.9M–$186.4M | ▼ -20.0% | $0.57 | ▼ -29.2% | ±2% | Low2 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryLFVN
Last 8Q
+7.3%avg beat
Beat 3 of 8 quartersMissed 3↑ Estimates rising-33%
Q3'24
—
Q4'24
+69%
Q1'25
+63%
Q2'25
—
Q3'25
+6%
Q4'25
-21%
Q1'26
-25%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →Analysts turning cautious
30d▲ 0▼ 1
90d▲ 0▼ 1
Lake StreetBuy → Hold
May 7
DOWNGRADE
Insider Activity
SEC Filings →6 Buys/0 SellsNet Buying
Lewis DarwinDir
$6K
Mar 16
BUY
Dayton JuddDir
$48K
Mar 2
BUY
Dayton JuddDir
$84K
Feb 27
BUY
Dayton JuddDir
$21K
Feb 26
BUY
Lewis DarwinDir
$21K
Feb 9
BUY
Lewis DarwinDir
$5K
Dec 15
BUY
Financials
Dividends3.48% yield
+13.6% avg annual growthAnnual Yield3.48%
Quarterly Div.$0.0500
Est. Annual / Share$0.20
FrequencyQuarterly
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26
Q2'26
Dividend per payment — last 8 periods
INSTITUTIONAL OWNERSHIP
1
CAPITAL MANAGEMENT CORP /VA
2.4M▲2
RENAISSANCE TECHNOLOGIES LLC
868K▼3
BlackRock, Inc.
770K▼4
DIMENSIONAL FUND ADVISORS LP
276K▼5
ENVESTNET ASSET MANAGEMENT INC
219K▲6
Advyzon Investment Management, LLC
108K▲7
NORTHERN TRUST CORP
91K▲8
PERKINS CAPITAL MANAGEMENT INC
75K—News & Activity
LFVN News
About
lifevantage is at the forefront of nutrigenomics, a new form of nutritional science that uses nutrients to create improved health and wellness. aging is inevitable. and we’re all painfully aware of the toll it takes on our bodies. nutrigenomics is serious science. and it’s graduated from the laboratory to real-life, creating a platform for products that really work – really.
Michael A. BeindorffInterim CEO & Director
Steven R. FifePresident, Chief Executive Officer & Director
Peers— Consumer Defensive(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
LFVN◀ | $5.17 | +0.98% | $65M | 11.3 | +1417.1% | 429.0% | 1500 |
| $131.45 | -0.76% | $1.0T | 47.9 | +472.5% | 307.0% | 1520 | |
| $1048.95 | +0.74% | $465.4B | 54.5 | +816.7% | 294.3% | 1507 | |
| $80.82 | +0.46% | $347.7B | 25.4 | +187.0% | 2734.0% | 1508 | |
| $141.57 | -0.80% | $329.7B | 20.5 | +29.2% | 1895.3% | 1486 | |
| $189.61 | -1.17% | $295.5B | 26.7 | +731.3% | 2791.8% | 1509 | |
| $149.12 | +0.30% | $203.8B | 23.3 | +225.5% | 877.3% | 1488 | |
| Sector avg | — | -0.04% | — | 29.9 | +554.2% | 1332.7% | 1503 |